Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Doherty

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Journal of Medicinal Chemistry|March 28, 1997
Structure-activity relationships in a series of orally active gamma-hydroxy butenolide endothelin antagonistsW C Patt, J J Edmunds, J T Repine, et al.
Journal of Medicinal Chemistry|October 28, 1997
C-terminal modifications of histidyl-N-benzylglycinamides to give improved inhibition of Ras farnesyltransferase, cellular activity, and anticancer activity in miceD J McNamara, E Dobrusin, D M Leonard, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 1999
The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: part 2W L Cody, C E Augelli-Szafran, K A Berryman, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Potent and selective bicyclic lactam inhibitors of thrombin: Part 2: P1 modificationsJ S Plummer, K A Berryman, C Cai, et al.
Journal of Medicinal Chemistry|December 22, 2000
Synthesis, structure-activity relationships, and pharmacological profile of 9-amino-4-oxo-1-phenyl-3,4,6,7-tetrahydro[1,4]diazepino[6, 7,1-hi]indoles: discovery of potent, selective phosphodiesterase type 4 inhibitorsC Burnouf, E Auclair, N Avenel, et al.
Journal of Medicinal Chemistry|July 18, 1997
Structure-activity relationships for a novel series of pyrido[2,3-d]pyrimidine tyrosine kinase inhibitorsJ M Hamby, C J Connolly, M C Schroeder, et al.
Journal of Medicinal Chemistry|October 23, 1998
Synthesis and tyrosine kinase inhibitory activity of a series of 2-amino-8H-pyrido[2,3-d]pyrimidines: identification of potent, selective platelet-derived growth factor receptor tyrosine kinase inhibitorsD H Boschelli, Z Wu, S R Klutchko, et al.
Journal of Medicinal Chemistry|June 1, 2001
Soluble 2-substituted aminopyrido[2,3-d]pyrimidin-7-yl ureas. Structure-activity relationships against selected tyrosine kinases and exploration of in vitro and in vivo anticancer activityM C Schroeder, J M Hamby, C J Connolly, et al.
Journal of Medicinal Chemistry|August 14, 1998
2-Substituted aminopyrido[2,3-d]pyrimidin-7(8H)-ones. structure-activity relationships against selected tyrosine kinases and in vitro and in vivo anticancer activityS R Klutchko, J M Hamby, D H Boschelli, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Journal of Medicinal Chemistry|March 28, 1997
Structure-activity relationships in a series of orally active gamma-hydroxy butenolide endothelin antagonistsW C Patt, J J Edmunds, J T Repine, et al.
Journal of Medicinal Chemistry|October 28, 1997
C-terminal modifications of histidyl-N-benzylglycinamides to give improved inhibition of Ras farnesyltransferase, cellular activity, and anticancer activity in miceD J McNamara, E Dobrusin, D M Leonard, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 1999
The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: part 2W L Cody, C E Augelli-Szafran, K A Berryman, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Potent and selective bicyclic lactam inhibitors of thrombin: Part 2: P1 modificationsJ S Plummer, K A Berryman, C Cai, et al.
Journal of Medicinal Chemistry|December 22, 2000
Synthesis, structure-activity relationships, and pharmacological profile of 9-amino-4-oxo-1-phenyl-3,4,6,7-tetrahydro[1,4]diazepino[6, 7,1-hi]indoles: discovery of potent, selective phosphodiesterase type 4 inhibitorsC Burnouf, E Auclair, N Avenel, et al.
Journal of Medicinal Chemistry|July 18, 1997
Structure-activity relationships for a novel series of pyrido[2,3-d]pyrimidine tyrosine kinase inhibitorsJ M Hamby, C J Connolly, M C Schroeder, et al.
Journal of Medicinal Chemistry|October 23, 1998
Synthesis and tyrosine kinase inhibitory activity of a series of 2-amino-8H-pyrido[2,3-d]pyrimidines: identification of potent, selective platelet-derived growth factor receptor tyrosine kinase inhibitorsD H Boschelli, Z Wu, S R Klutchko, et al.
Journal of Medicinal Chemistry|June 1, 2001
Soluble 2-substituted aminopyrido[2,3-d]pyrimidin-7-yl ureas. Structure-activity relationships against selected tyrosine kinases and exploration of in vitro and in vivo anticancer activityM C Schroeder, J M Hamby, C J Connolly, et al.
Journal of Medicinal Chemistry|August 14, 1998
2-Substituted aminopyrido[2,3-d]pyrimidin-7(8H)-ones. structure-activity relationships against selected tyrosine kinases and in vitro and in vivo anticancer activityS R Klutchko, J M Hamby, D H Boschelli, et al.
Pageof 9